ROBERTI, ROBERTA
 Distribuzione geografica
Continente #
NA - Nord America 1.213
AS - Asia 570
EU - Europa 410
SA - Sud America 148
Continente sconosciuto - Info sul continente non disponibili 57
AF - Africa 42
OC - Oceania 9
Totale 2.449
Nazione #
US - Stati Uniti d'America 1.143
SG - Singapore 229
IT - Italia 201
CN - Cina 109
BR - Brasile 102
VN - Vietnam 81
DE - Germania 54
IN - India 47
CA - Canada 28
HK - Hong Kong 28
GB - Regno Unito 24
FI - Finlandia 20
RU - Federazione Russa 19
SE - Svezia 19
AR - Argentina 16
BD - Bangladesh 16
EG - Egitto 16
NL - Olanda 16
CO - Colombia 13
ES - Italia 12
PL - Polonia 12
MX - Messico 11
IL - Israele 10
IQ - Iraq 9
SC - Seychelles 9
AU - Australia 8
JP - Giappone 8
TT - Trinidad e Tobago 8
ID - Indonesia 7
EE - Estonia 6
EC - Ecuador 5
FR - Francia 5
GT - Guatemala 5
NI - Nicaragua 5
CR - Costa Rica 4
UA - Ucraina 4
ZA - Sudafrica 4
BE - Belgio 3
CL - Cile 3
DZ - Algeria 3
KR - Corea 3
PK - Pakistan 3
TN - Tunisia 3
TR - Turchia 3
UZ - Uzbekistan 3
AT - Austria 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
GA - Gabon 2
GE - Georgia 2
GP - Guadalupe 2
GR - Grecia 2
HN - Honduras 2
LT - Lituania 2
OM - Oman 2
PE - Perù 2
PH - Filippine 2
PR - Porto Rico 2
SA - Arabia Saudita 2
SV - El Salvador 2
UY - Uruguay 2
VE - Venezuela 2
AL - Albania 1
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EU - Europa 1
GY - Guiana 1
IR - Iran 1
JO - Giordania 1
KE - Kenya 1
LB - Libano 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PY - Paraguay 1
QA - Qatar 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.394
Città #
San Jose 191
Ashburn 103
Singapore 91
Dallas 70
Chandler 68
Council Bluffs 49
Santa Clara 49
Munich 39
Beijing 36
Phoenix 31
Bengaluru 30
Los Angeles 28
Milan 27
Hefei 26
Hong Kong 26
Chicago 25
Ho Chi Minh City 24
Hanoi 21
New York 21
Rome 17
Turku 17
Boardman 15
London 14
Orem 14
Princeton 14
São Paulo 13
Lawrence 12
Naples 12
Warsaw 12
Cairo 11
Catanzaro 10
Des Moines 8
Florence 8
Amsterdam 7
Bogotá 7
Boston 7
Mexico City 7
San Francisco 7
Montreal 6
Tokyo 6
Wilmington 6
Atlanta 5
Baghdad 5
Buffalo 5
Collegeville 5
Da Nang 5
Managua 5
The Dalles 5
Assago 4
Brasília 4
Buenos Aires 4
Chennai 4
Dhaka 4
Guatemala City 4
Haiphong 4
Melbourne 4
Miami 4
Mumbai 4
Rio de Janeiro 4
Turin 4
Washington 4
Bari 3
Biên Hòa 3
Brooklyn 3
Charlotte 3
Denver 3
Helsinki 3
Madrid 3
Medellín 3
Mottola 3
Nuremberg 3
Perugia 3
Philadelphia 3
Quito 3
Redwood City 3
Roanoke 3
San José 3
Surrey 3
Toronto 3
Abbeville 2
Algiers 2
Annapolis 2
Athens 2
Bergamo 2
Brussels 2
Campinas 2
Canberra 2
Canton 2
Chaguanas 2
Columbus 2
Comiso 2
Cosenza 2
Couva 2
Curinga 2
El Monte 2
Faenza 2
Frankfurt am Main 2
Genoa 2
Giugliano in Campania 2
Guadalajara 2
Totale 1.368
Nome #
Pharmacology of Cenobamate: Mechanism of Action, Pharmacokinetics, Drug–Drug Interactions and Tolerability 178
Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy 172
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study 94
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 93
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 91
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 89
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 84
Status epilepticus in pregnancy: a literature review and a protocol proposal 81
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 80
Assessing knowledge and attitudes toward epilepsy among schoolteachers and students: Implications for inclusion and safety in the educational system 74
Epidemiology and outcomes of status epilepticus 74
Gut Microbiota Profile Changes in Patients with Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease: A Metagenomic Study 71
Pharmacokinetic considerations about antiseizure medications in the elderly 71
Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice 70
SARS-CoV-2 treatment: Current therapeutic options and the pursuit of tailored therapy 70
Clinically relevant drug interactions between statins and antidepressants 69
Exploring the Effectiveness of Adjunctive Cenobamate in Focal Epilepsy: A Time-Based Analysis 67
Drug–drug interactions in vestibular diseases, clinical problems, and medico-legal implications 66
Anti-seizure medications in patients with renal failure undergoing dialysis: how to manage? 65
Appropriate use of generic and branded antiseizure medications in epilepsy: Updated recommendations from the Italian League Against Epilepsy (LICE) 61
Asthma control during COVID-19 lockdown in patients with severe asthma under biological drug treatment 61
Management of status epilepticus in patients with liver or kidney disease: a narrative review 57
High-Intensity, Low-Frequency Pulsed Electromagnetic Field as an Odd Treatment in a Patient with Mixed Foot Ulcer: A Case Report 55
In Web We Trust: The Promised Cannabidiol Effects on Obesity as a Matter of Language and Marketing on Webpages 55
The Mental Health of Caregivers and Their Patients With Dementia During the COVID-19 Pandemic: A Systematic Review 55
A real-life pilot study of the clinical application of pharmacogenomics testing on saliva in epilepsy 51
Cannabidiol Add-On in Glycosylphosphatidylinositol-Related Drug-Resistant Epilepsy 50
Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar Efficacy 46
Pilot study on the probability of drug-drug interactions among direct oral anticoagulants (DOACs) and antiseizure medications (ASMs): a clinical perspective 42
Effect of patient-related factors on brivaracetam efficacy and tolerability: results from a multicentric, retrospective study 35
Cannabidiol plus everolimus for the treatment of TSC: two cases 25
Prehospital rescue treatment of cluster epileptic seizures and status epilepticus 23
Safety and efficacy of third-generation antiseizure medications: Real-world data from a multicentric retrospective study 22
A proposal for a shared therapeutic algorithm in children with prolonged convulsive seizures and status epilepticus 21
Evaluating bexicaserin for the treatment of developmental epileptic encephalopathies 18
May I, compare? 18
Drug-drug interaction between anti-seizure medications in Dravet syndrome and Lennox-Gastaut syndrome 17
Cenobamate as add-on therapy for drug resistant epilepsies: effectiveness, drug to drug interactions and neuropsychological impact. What have we learned from real word evidence? 17
Pharmacodynamic rationale for the choice of antiseizure medications in the paediatric population 17
Sodium Butyrate ameliorates pain and mood disorders in a mouse model of Parkinson disease 13
The real-world effectiveness of intravenous brivaracetam as a second-line treatment in status epilepticus 11
Soticlestat for drug-resistant epilepsy: Current evidence and clinical perspectives 10
DECREASE study: A European pool‐analysis of patients with significant reductions in concomitant antiseizure medications in cenobamate Early Access Programs 10
Totale 2.449
Categoria #
all - tutte 15.595
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.595


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202250 0 0 0 0 2 8 0 10 3 2 25 0
2022/2023176 26 24 3 20 15 18 0 10 35 13 10 2
2023/2024113 12 15 17 5 7 17 6 0 1 4 11 18
2024/2025330 30 4 1 12 38 31 14 12 31 10 56 91
2025/20261.187 51 92 128 126 90 52 138 100 164 113 61 72
2026/2027529 25 92 177 145 90 0 0 0 0 0 0 0
Totale 2.449